 | • レポートコード：MRC2Q12-19349 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、術後鎮痛剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 術後鎮痛剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 術後鎮痛剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 術後鎮痛剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの術後鎮痛剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の術後鎮痛剤の売上および2028年までの予測に焦点を当てています。 術後鎮痛剤のグローバル主要企業には、Mallinckrodt Pharmaceuticals、Pfizer、Novartis、Eli Lilly、Teva Pharmaceutical Industries、Camurus、Bayer、Pacira BioSciences、Trevenaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 術後鎮痛剤市場は、タイプとアプリケーションによって区分されます。世界の術後鎮痛剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他 【アプリケーション別セグメント】 病院薬局、小売店、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 術後鎮痛剤製品概要 - タイプ別市場（オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他） - アプリケーション別市場（病院薬局、小売店、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の術後鎮痛剤販売量予測2017-2028 - 世界の術後鎮痛剤売上予測2017-2028 - 術後鎮痛剤の地域別販売量 - 術後鎮痛剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別術後鎮痛剤販売量 - 主要メーカー別術後鎮痛剤売上 - 主要メーカー別術後鎮痛剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他） - 術後鎮痛剤のタイプ別販売量 - 術後鎮痛剤のタイプ別売上 - 術後鎮痛剤のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店、オンライン薬局、その他） - 術後鎮痛剤のアプリケーション別販売量 - 術後鎮痛剤のアプリケーション別売上 - 術後鎮痛剤のアプリケーション別価格 ・北米市場 - 北米の術後鎮痛剤市場規模（タイプ別、アプリケーション別） - 主要国別の術後鎮痛剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの術後鎮痛剤市場規模（タイプ別、アプリケーション別） - 主要国別の術後鎮痛剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の術後鎮痛剤市場規模（タイプ別、アプリケーション別） - 主要国別の術後鎮痛剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の術後鎮痛剤市場規模（タイプ別、アプリケーション別） - 主要国別の術後鎮痛剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの術後鎮痛剤市場規模（タイプ別、アプリケーション別） - 主要国別の術後鎮痛剤市場規模（トルコ、サウジアラビア） ・企業情報 Mallinckrodt Pharmaceuticals、Pfizer、Novartis、Eli Lilly、Teva Pharmaceutical Industries、Camurus、Bayer、Pacira BioSciences、Trevena ・産業チェーン及び販売チャネル分析 - 術後鎮痛剤の産業チェーン分析 - 術後鎮痛剤の原材料 - 術後鎮痛剤の生産プロセス - 術後鎮痛剤の販売及びマーケティング - 術後鎮痛剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 術後鎮痛剤の産業動向 - 術後鎮痛剤のマーケットドライバー - 術後鎮痛剤の課題 - 術後鎮痛剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Postoperative Pain Control include Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences and Trevena, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Postoperative Pain Control manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Postoperative Pain Control market. Further, it explains the major drivers and regional dynamics of the global Postoperative Pain Control market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mallinckrodt Pharmaceuticals
Pfizer
Novartis
Eli Lilly
Teva Pharmaceutical Industries
Camurus
Bayer
Pacira BioSciences
Trevena
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Postoperative Pain Control Segment by Type
Opioids
NSAIDs
Local Anesthetics
Tricyclic Antidepressants
Antiepileptic drugs
Others
Postoperative Pain Control Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Postoperative Pain Control market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Postoperative Pain Control, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Postoperative Pain Control, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Postoperative Pain Control, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Postoperative Pain Control sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Postoperative Pain Control market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Postoperative Pain Control sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences and Trevena, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Postoperative Pain Control in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Postoperative Pain Control manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postoperative Pain Control sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Postoperative Pain Control Product Introduction
1.2 Market by Type
1.2.1 Global Postoperative Pain Control Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Opioids
1.2.3 NSAIDs
1.2.4 Local Anesthetics
1.2.5 Tricyclic Antidepressants
1.2.6 Antiepileptic drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Pain Control Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Postoperative Pain Control Sales Estimates and Forecasts 2017-2028
2.2 Global Postoperative Pain Control Revenue Estimates and Forecasts 2017-2028
2.3 Global Postoperative Pain Control Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Postoperative Pain Control Sales by Region
2.4.1 Global Postoperative Pain Control Sales by Region (2017-2022)
2.4.2 Global Sales Postoperative Pain Control by Region (2023-2028)
2.5 Global Postoperative Pain Control Revenue by Region
2.5.1 Global Postoperative Pain Control Revenue by Region (2017-2022)
2.5.2 Global Postoperative Pain Control Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Postoperative Pain Control Sales by Manufacturers
3.1.1 Global Top Postoperative Pain Control Manufacturers by Sales (2017-2022)
3.1.2 Global Postoperative Pain Control Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Postoperative Pain Control in 2021
3.2 Global Postoperative Pain Control Revenue by Manufacturers
3.2.1 Global Postoperative Pain Control Revenue by Manufacturers (2017-2022)
3.2.2 Global Postoperative Pain Control Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Postoperative Pain Control Revenue in 2021
3.3 Global Postoperative Pain Control Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Postoperative Pain Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Postoperative Pain Control Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Postoperative Pain Control Sales by Type
4.1.1 Global Postoperative Pain Control Historical Sales by Type (2017-2022)
4.1.2 Global Postoperative Pain Control Forecasted Sales by Type (2023-2028)
4.1.3 Global Postoperative Pain Control Sales Market Share by Type (2017-2028)
4.2 Global Postoperative Pain Control Revenue by Type
4.2.1 Global Postoperative Pain Control Historical Revenue by Type (2017-2022)
4.2.2 Global Postoperative Pain Control Forecasted Revenue by Type (2023-2028)
4.2.3 Global Postoperative Pain Control Revenue Market Share by Type (2017-2028)
4.3 Global Postoperative Pain Control Price by Type
4.3.1 Global Postoperative Pain Control Price by Type (2017-2022)
4.3.2 Global Postoperative Pain Control Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Postoperative Pain Control Sales by Application
5.1.1 Global Postoperative Pain Control Historical Sales by Application (2017-2022)
5.1.2 Global Postoperative Pain Control Forecasted Sales by Application (2023-2028)
5.1.3 Global Postoperative Pain Control Sales Market Share by Application (2017-2028)
5.2 Global Postoperative Pain Control Revenue by Application
5.2.1 Global Postoperative Pain Control Historical Revenue by Application (2017-2022)
5.2.2 Global Postoperative Pain Control Forecasted Revenue by Application (2023-2028)
5.2.3 Global Postoperative Pain Control Revenue Market Share by Application (2017-2028)
5.3 Global Postoperative Pain Control Price by Application
5.3.1 Global Postoperative Pain Control Price by Application (2017-2022)
5.3.2 Global Postoperative Pain Control Price Forecast by Application (2023-2028)
6 North America
6.1 North America Postoperative Pain Control Market Size by Type
6.1.1 North America Postoperative Pain Control Sales by Type (2017-2028)
6.1.2 North America Postoperative Pain Control Revenue by Type (2017-2028)
6.2 North America Postoperative Pain Control Market Size by Application
6.2.1 North America Postoperative Pain Control Sales by Application (2017-2028)
6.2.2 North America Postoperative Pain Control Revenue by Application (2017-2028)
6.3 North America Postoperative Pain Control Market Size by Country
6.3.1 North America Postoperative Pain Control Sales by Country (2017-2028)
6.3.2 North America Postoperative Pain Control Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Postoperative Pain Control Market Size by Type
7.1.1 Europe Postoperative Pain Control Sales by Type (2017-2028)
7.1.2 Europe Postoperative Pain Control Revenue by Type (2017-2028)
7.2 Europe Postoperative Pain Control Market Size by Application
7.2.1 Europe Postoperative Pain Control Sales by Application (2017-2028)
7.2.2 Europe Postoperative Pain Control Revenue by Application (2017-2028)
7.3 Europe Postoperative Pain Control Market Size by Country
7.3.1 Europe Postoperative Pain Control Sales by Country (2017-2028)
7.3.2 Europe Postoperative Pain Control Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Postoperative Pain Control Market Size by Type
8.1.1 Asia Pacific Postoperative Pain Control Sales by Type (2017-2028)
8.1.2 Asia Pacific Postoperative Pain Control Revenue by Type (2017-2028)
8.2 Asia Pacific Postoperative Pain Control Market Size by Application
8.2.1 Asia Pacific Postoperative Pain Control Sales by Application (2017-2028)
8.2.2 Asia Pacific Postoperative Pain Control Revenue by Application (2017-2028)
8.3 Asia Pacific Postoperative Pain Control Market Size by Region
8.3.1 Asia Pacific Postoperative Pain Control Sales by Region (2017-2028)
8.3.2 Asia Pacific Postoperative Pain Control Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Postoperative Pain Control Market Size by Type
9.1.1 Latin America Postoperative Pain Control Sales by Type (2017-2028)
9.1.2 Latin America Postoperative Pain Control Revenue by Type (2017-2028)
9.2 Latin America Postoperative Pain Control Market Size by Application
9.2.1 Latin America Postoperative Pain Control Sales by Application (2017-2028)
9.2.2 Latin America Postoperative Pain Control Revenue by Application (2017-2028)
9.3 Latin America Postoperative Pain Control Market Size by Country
9.3.1 Latin America Postoperative Pain Control Sales by Country (2017-2028)
9.3.2 Latin America Postoperative Pain Control Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Postoperative Pain Control Market Size by Type
10.1.1 Middle East and Africa Postoperative Pain Control Sales by Type (2017-2028)
10.1.2 Middle East and Africa Postoperative Pain Control Revenue by Type (2017-2028)
10.2 Middle East and Africa Postoperative Pain Control Market Size by Application
10.2.1 Middle East and Africa Postoperative Pain Control Sales by Application (2017-2028)
10.2.2 Middle East and Africa Postoperative Pain Control Revenue by Application (2017-2028)
10.3 Middle East and Africa Postoperative Pain Control Market Size by Country
10.3.1 Middle East and Africa Postoperative Pain Control Sales by Country (2017-2028)
10.3.2 Middle East and Africa Postoperative Pain Control Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Overview
11.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mallinckrodt Pharmaceuticals Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt Pharmaceuticals Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Corporation Information
11.5.2 Teva Pharmaceutical Industries Overview
11.5.3 Teva Pharmaceutical Industries Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Pharmaceutical Industries Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Industries Recent Developments
11.6 Camurus
11.6.1 Camurus Corporation Information
11.6.2 Camurus Overview
11.6.3 Camurus Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Camurus Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Camurus Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Pacira BioSciences
11.8.1 Pacira BioSciences Corporation Information
11.8.2 Pacira BioSciences Overview
11.8.3 Pacira BioSciences Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pacira BioSciences Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pacira BioSciences Recent Developments
11.9 Trevena
11.9.1 Trevena Corporation Information
11.9.2 Trevena Overview
11.9.3 Trevena Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Trevena Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Trevena Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Postoperative Pain Control Industry Chain Analysis
12.2 Postoperative Pain Control Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Postoperative Pain Control Production Mode & Process
12.4 Postoperative Pain Control Sales and Marketing
12.4.1 Postoperative Pain Control Sales Channels
12.4.2 Postoperative Pain Control Distributors
12.5 Postoperative Pain Control Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Postoperative Pain Control Industry Trends
13.2 Postoperative Pain Control Market Drivers
13.3 Postoperative Pain Control Market Challenges
13.4 Postoperative Pain Control Market Restraints
14 Key Findings in The Global Postoperative Pain Control Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【術後鎮痛剤について】 術後鎮痛剤は、手術後の疼痛管理に使用される薬物や治療法であり、患者の回復や生活の質を向上させる重要な役割を果たします。手術は体に大きな負担をかけるため、術後には痛みや不快感を伴うことが多く、これに対処するために適切な鎮痛剤が必要となります。術後疼痛は、手術の種類や患者の状態によって異なり、個々の患者に対して適切な鎮痛戦略を選択することが求められます。 術後鎮痛剤の特徴としては、まずその効果の速さや持続時間があります。鎮痛剤は、即効性を持つものと、徐々に効果が現れるものがあり、手術後の痛みの程度や患者の反応に応じて使い分けられます。さらに、薬物の副作用や投与方法も考慮する必要があります。経口投与、静脈注射、局所麻酔など、さまざまな投与ルートがあり、患者の状態や手術の内容に応じた選択が重要です。 術後鎮痛剤には、主に以下のような種類があります。第一に、非オピオイド鎮痛剤としてイブプロフェンやアセトアミノフェンがあり、軽度から中程度の痛みを和らげる際に使用されます。これらの薬剤は比較的副作用が少なく、使用が容易です。第二に、オピオイド鎮痛剤があり、モルヒネやオキシコドンなどが含まれます。これらは強い痛みの管理に効果的ですが、依存症や副作用のリスクが高いため、注意が必要です。オピオイドは通常、出血や神経損傷などにより強い痛みを感じる場合に用いられ、場合によってはガイドラインに従って段階的に投与されることが一般的です。 さらに、アジュバント療法というアプローチもあり、抗うつ薬や抗痙攣薬が鎮痛に寄与することがあります。これらの薬剤は、神経病理性疼痛に対して特に効果があるとされています。例えば、ガバペンチンやプレガバリンは、神経系における痛みの伝達を抑制し、術後の疼痛管理に有効です。 術後鎮痛剤の用途は多岐にわたり、医療機関では患者の手術後の痛みを評価し、その痛みの程度に基づいて適切な鎮痛剤を選定します。柔軟な疼痛管理が求められ、術後の早期回復を促進するためには、痛みの種類や患者の個々の反応に応じた治療が重要です。また、術後疼痛の管理は、患者の入院期間やリハビリテーションの進行にも影響を与えるため、医療従事者は慎重な対応が必要です。 関連技術としては、持続的硬膜外麻酔や局所麻酔薬の持続的注入システムがあります。これにより、痛みを効果的に管理し、オピオイドの使用量を減少させることが可能です。また、神経ブロック技術も有用であり、特定の神経を標的としたブロックが術後の疼痛を軽減するのに役立ちます。これにより、患者の快適性が向上し、合併症のリスクも低減します。 さらに、最近の研究では、術後の疼痛に対する新しいアプローチとして、エビデンスに基づく多モダリティ疼痛管理の重要性が強調されています。これは、複数の鎮痛薬や技術を組み合わせることで、相乗的な効果を得ることを目的としています。このアプローチにより、薬剤の使用を最小限に抑えつつ、効果的な疼痛管理を実現することができます。 患者の疼痛管理に対するアプローチは、個別化医療の流れに沿って進化しており、患者のニーズや価値観を尊重することが求められます。医療従事者は、術後鎮痛の選択肢を理解し、患者とコミュニケーションを取りながら最適な治療法を提示することが大切です。また、患者自身が疼痛を正直に報告し、医療従事者と共に最適な治療法を見出すことも重要な要素です。 以上のように、術後鎮痛剤は、手術後の疼痛管理において極めて重要な役割を果たしており、その使用方法や種類には多くの選択肢があります。医療現場においては、患者に合わせた適切な鎮痛戦略を選択することが、術後回復の促進や患者の生活の質の向上に大きく寄与します。今後も、より効果的で安全な疼痛管理の方法が求められ、研究や技術の進歩が期待されます。 |